The effect of KY1005-2D10 in the human skin transplant model of psoriasis.

The effect of KY1005-2D10 in the human skin transplant model of psoriasis. - Transplant model of psoriasis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42911

Enrollment

Registered

2016-08-16

Start date

2016-09-20

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

model

psoriasis

transplant

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe psoriasis

Exclusion criteria

Exclusion criteria: Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate Volunteers using local topical corticosteroids Volunteers developing psoriasis at wound sites (Köbner phenomenon)

Design outcomes

Primary

Measure	Time frame
Effect on typical psoriasis skin features after treatment with KY1005-2D10.	—

Secondary

Measure	Time frame
-	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)